Results 21 to 30 of about 249,373 (343)

An Increasing Burden of Disease: Emergency Department Visits Among Patients With Ventricular Assist Devices From 2010 to 2017

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background With a growing population of patients supported by ventricular assist devices (VADs) and the improvement in survival of this patient population, understanding the healthcare system burden is critical to improving outcomes.
Jonathan B. Edelson   +18 more
doaj   +1 more source

Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation.

open access: yesInteractive Cardiovascular and Thoracic Surgery, 2020
OBJECTIVES Right heart failure after left ventricular assist device (LVAD) implantation is associated with significant morbidity and mortality. A new generation of percutaneous right ventricular assist devices (RVADs) may mitigate the need for invasive ...
M. Salna   +11 more
semanticscholar   +1 more source

Factors influencing transfusion-associated HLA sensitization in patients bridged to heart transplantation using ventricular assist device. [PDF]

open access: yes, 2020
BackgroundBridging heart failure patients with mechanical ventricular assist devices (VAD) enables access to transplantation. However, VAD is associated with increased risk for anti-HLA antibodies associated with rejection of subsequent allografts ...
Adler, Eric   +5 more
core   +1 more source

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients The ROADMAP Study 2-Year Results [PDF]

open access: yes, 2017
OBJECTIVES The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years ...
Boyle, Andrew J.   +15 more
core   +2 more sources

Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry.

open access: yesEuropean Heart Journal, 2020
AIMS The ELEVATE Registry was designed to study long-term outcomes with the Heartmate 3 (HM3), a fully magnetically levitated centrifugal ventricular assist device, in a real-world population following CE-mark approval.
D. Zimpfer   +12 more
semanticscholar   +1 more source

Left Ventricular Assist Device-Related Complications

open access: yesJournal of Cardiovascular Emergencies, 2020
Left ventricular assist device (LVAD) has emerged as a safe, durable, and revolutionary therapy for end-stage heart failure patients. Despite the appearance of newer-generation devices that have improved patient outcomes, the burden of adverse events ...
Clement Alexandra   +3 more
doaj   +1 more source

Pressure, Flow Rate and Operating Speed Characteristics of a Continuous Flow Left Ventricular Assist Device During Varying Speed Support

open access: yesIEEE Access, 2020
Hydraulic performance of Continuous Flow Left Ventricular Assist Devices depends on their pressure head and flow rate relations. Hydraulic characteristics of these devices are expressed by pressure head and flow rate loops in a pulsatile environment as ...
Selim Bozkurt
doaj   +1 more source

Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study

open access: yesESC Heart Failure, 2020
Sufficient myocardial recovery with the subsequent explantation of a left ventricular assist device (LVAD) occurs in approximately 1–2% of the cases. However, follow‐up data about this condition are scarcely available in the literature.
C. Antonides   +12 more
semanticscholar   +1 more source

In Full Flow: Left Ventricular Assist Device Infections in the Modern Era

open access: yesOpen Forum Infectious Diseases, 2020
With the rising prevalence of heart disease in the United States, there is increasing reliance on durable mechanical circulatory support (MCS) to treat patients with end-stage heart failure.
Radoslav Zinoviev   +3 more
semanticscholar   +1 more source

Implications of Transitional Care Interventions on Hospital Readmissions in Patients With Destination Therapy Left Ventricular Assist Devices [PDF]

open access: yes, 2019
Background: The rising number of patients with a left ventricular assist device (LVAD) require care management to successfully transition home after implantation. These patients and their families need to manage their heart failure, and the complexities
Hirschman, Karen   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy